 BOSTON, Jan. 07, 2022 GLOBE NEWSWIRE -- Akouos, Inc. NASDAQ: AKUS, a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced that new nonclinical data will be presented at the Association for Research in Otolaryngology ARO 45th Annual Mid-Winter Meeting, which is being held in San Jose, California from February 5 to 9, 2022. 